Abstract. Prop1 is one of several transcription factors important for the development of the pituitary gland. Downstream targets of PROP1 and other critical pituitary transcription factors remain largely unknown. We have generated a partial expression profile of the developing pituitary gland containing over 350 transcripts, using cDNA subtractive hybridization between Prop1 df/df and wild-type embryonic pituitary gland primordia. Numerous classes of genes including transcription factors, membrane associated molecules, and cell cycle regulators were identified in this study. Of the transcripts, 34% do not have sequence similarity to known genes, but are similar to ESTs, and 4% represent novel sequences. Pituitary gland expression of a number of clones was verified using in situ hybridization.
Introduction
The rodent pituitary gland is composed of the anterior, intermediate, and posterior lobes. The anterior lobe contains five hormoneproducing cell types that secrete hormones necessary for growth, fertility, lactation, response to physiological stress, and thyroid function. The major secretory product of the intermediate lobe is melanocyte-stimulating hormone; oxytocin and vasopressin are produced in the posterior lobe.
The anlage of the pituitary gland begins to develop at embryonic day 9.0 (e9.0) in response to inductive signals provided by surrounding tissues (Treier and Rosenfeld 1996; Burrows et al. 1999; Sheng and Westphal 1999) . Over the next several days, signals from the ventral diencephalon and juxtaposed mesenchymal cells induce spatially restricted patterns of transcription factor expression in the nascent pituitary. Stratified transcription factor domains are translated into distinct regions of cell differentiation within the gland. Several critical genes regulating pituitary gland development have been identified through the characterization of hereditary mouse and human pituitary endocrine deficiencies. The pituitary transcription factors Pitx2, Lhx3, Hesx1, and Prop1 are each essential for pituitary gland development; however, their downstream targets remain largely unknown.
Differential gene expression analysis is invaluable for gaining a better understanding of the molecular events regulating pituitary gland development. The RIKEN group (http://genome.rtc.riken. go.jp) released a large transcriptome from adult male pituitary (Aizawa et al. 2000) . Although this is a rich resource for the identification of genes important for adult pituitary function, embryo-specific genes such as Hesx1 and Prop1 are not represented. We demonstrated the feasibility of establishing an expression profile of the developing organ using differential display to compare transcripts present at e12.5 and e14.5 in the pituitary primordium. This is a period of intense cell proliferation (Carbajo-Perez et al. 1989) preceding the differentiation of four of the five mature cell types and a time when the effects of mutations in Pitx2, Lhx3, Hesx1, and Prop1 are evident. We reported a limited transcriptome, including two validated, novel, differential transcripts (Douglas and Camper 2000) . Here, we describe a library of pituitary transcripts not previously reported that are expressed at e14.5. This library was generated by using cDNA subtractive hybridization comparing normal pituitary primodia with Prop1 df/df mutants. Analysis of both libraries reveals that numerous members of the Wnt signaling pathway are expressed in the developing pituitary gland. Several Wnt genes, including Wnt4, Wnt5a, and Wnt10a, are known to be expressed in or adjacent to the developing gland (Wang and Shackleford 1996; Treier et al. 1998) , and Wnt4 has been shown to have a functional role in pituitary gland development (Treier et al. 1998 ). We identified a novel TCF4 isoform (the Tcf4 gene is officially named Tcf7l2), frizzled2, adenomatosis polyposis coli (Apc), beta-catenin, and groucho in the developing pituitary. The presence of several members of the Wnt signaling pathway in these pituitary libraries supports the importance of Wnt signaling in the development of the pituitary gland.
Materials and methods
Mice and genotyping. Swiss Webster mice were purchased from CD1 and Prop1 df/+ stocks were maintained at the University of Michigan according to NIH guidelines, and all experiments were approved by the University of Michigan Committee on Use and Care of Animals.
Embryonic material for the cDNA subtraction was generated from Prop1 df/+ heterozygous matings. Developing pituitary glands were dissected from embryonic day 14.5 (e14.5) embryos with the aid of a dissection microscope and were individually frozen at −80°C resting on approximately 50 l Trizol (Gibco BRL, Gaithersburg, Md.). Embryos were genotyped, and pituitaries of the same genotype were pooled for RNA extraction.
A HinfI restriction fragment length polymorphism (RFLP) was utilized to genotype embryos generated from Prop1 df/+ × Prop1 df/+ matings. The point mutation in the Prop1 df allele eliminates a HinfI restriction site. Genomic DNA for genotyping assays was extracted from embryonic tails, and approximately 200-500 ng genomic DNA was used as a template for PCR amplification with Prop1-specific primers (5Ј GAGCTGGG-GAGACCTAAGCTTTGCC and 5Ј GCCCAGATGTCAGGATACTG) in a 25-l reaction volume containing 1× Taq polymerase buffer, 0.5 mM each primer, 0.2 mM dNTPs, 0.2 l BSA (20mg/ml stock), and 0.5 U Taq polymerase under the following cycling parameters: 94°C, 3 min, followed by 30 cycles of 94°C, 30 s; 56°C, 30 s; 72°C, 30 s; followed by a 10-min extension at 72°C. Following amplification, PCR products were incubated with 2U HinfI (Roche, Indianapolis, Ind.) at 37°C for 2 h. Digested PCR products were resolved on 2% agarose gels. df/df pituitary transcripts were used as the "driver" and were subtracted away from Prop1 +/+ transcripts, the "tester." Following two rounds of subtraction and the suppression PCR step of this protocol, the subtracted pool of transcripts was T-tail cloned into the pGEMT-easy vector (Promega, Madison, Wis.) . Approximately 500 subtracted clones were randomly selected for further analysis.
Sequence analysis. All DNA sequencing was performed on ABI Models 377XL, 373XL, or 373A automated DNA sequencers at the University of Michigan sequencing core. Sequences obtained were compared with known genes via BLASTn (Altschul et al. 1997 ) searches of the nonredundant (nr) database through the NCBI BLAST website (http:// www.ncbi.nlm.nih.gov/BLAST/). After single-pass sequencing from the T7 promoter of the pGEMT-easy vector, selected clones were sequenced from the opposite end of the insert to obtain the complete insert sequence. Multiple DNA sequences were aligned by using the ClustalW alignment option of MacVector 6.5.3 (Oxford Molecular Group, Inc, Campbell, Calif.) Mapping. The differential display clone SAC183 and the Tcf7l2 gene were mapped on the T31 mouse/hamster radiation hybrid panel (Research Genetics, Huntsville, Als.) as previously described (Douglas and Camper 2000) . PCR primers from the divergent region of SAC183 [5ЈGTGAGTC-GCTGTGACTTCTTG (primer 2, Fig. 2 ) and 5ЈTTATACCCGCACAT-GTCCAC (primer 3, Fig. 2) ] and from the 3ЈUTR of Tcf7l2 (5ЈCCTGTC-CATGATGCCTCC and 5ЈACACTTCAATCAAGCAGGGG) were used for mapping. Tcf7l2 3Ј UTR sequences were designed to the Tcf7l2B isoform described by Korinek et al. (1998) .
RT-PCR and PCR. Two independent RNA samples from each tissue examined were analyzed for expression of transcripts as previously described (Douglas and Camper 2000) . RT-PCR was performed with primers designed to the divergent region of SAC183 (listed in mapping methods) and to SAC265 (5ЈAGTCCGGACCTGGGAGAG and 5ЈAATACCTCAT-GACGCTCATCG). Embryonic heads, bodies, and pituitaries from e12.5 and e14.5 embryos were surveyed for expression along with adult lung, spleen, kidney, brain, skeletal muscle, liver, heart, testis, and eye. Pituitary cell lines representing Pit1 precursor (GHFT1; Lew et al. 1993 ), corticotrope-like (G7, an AtT20 derivative; Gumbiner and Kelly 1982) , gonadotrope-like (␣T3; Windle et al. 1990 ), thyrotrope-like (␣TSH; Akerblom et al. 1990) , and somatomammotrope-like (GH3; Tashjian et al. 1968 ) cells were surveyed for expression.
The genomic structure of Tcf7l2 in the region of the SAC183 divergent exon was determined by comparing C57BL/6J genomic DNA to the SAC183 differential display clone. Expand Taq polymerase (Roche) was used to amplify a 4.2-kb C57BL/6J genomic PCR product by using the following primers: 5ЈGAAATCCACCTCCGCACTTA and 5ЈTTATAC-CCGCACATGTCCAC (primers 1 and 3, Fig. 2 ). The genomic product was cloned into pGEMT-easy (Promega) and sequenced.
Longer cDNAs representing SAC183 containing transcripts were amplified from e12.5 and e14.5 pituitary cDNA by using an SAC183-specific primer and an oligonucleotide designed to the 5ЈUTR of Tcf7l2B described by Korinek et al. (1998) : 5ЈTTATACCCGCACATGTCCAC (primer 3, Fig. 2 ) and 5ЈGGGGGGACTCGCAAAACT, respectively.
An adult pituitary cDNA library was screened by PCR (Gage and Camper 1997) by using SAC265 specific primers to identify the partial frizzled2 cDNA reported here.
In situ hybridization. In situ hybridization was performed on 6-paraffin sections of e12.5 embryos or 18-20 cryosections of e14.5 wild-type embryos. Antisense and sense probes were labeled with 10× DIG RNA labeling mix (Roche). For cryosectioned tissue, slides were warmed to room temperature for 30 min, then fixed in 4% paraformaldehyde/1× PBS for 30 min. Paraffin-embedded sections were deparaffinized by soaking in xylene 2× 10 min and rehydrated. After extensive 1× PBS washes, slides were treated with proteinase K: 0.1 g/ml for 5 min (cryosections) or 10 g/ml for 15 min (paraffin sections) at 37°C in prewarmed proteinase K buffer (100 mM Tris, pH 8.2; 50 mM EDTA) and subsequently washed in RNase-free water followed by 1× PBS. Sections were acetylated by equilibrating slides in 0.1 M triethanolamine (TEA; Sigma, St. Louis, Mo.) for 5-10 min followed by a 10-min incubation in 0.1 M TEA/0.25% acetic anhydride (Sigma) and washed three times in 1× PBS. Sections were prehybridized in a 5× SSC humidified chamber at 57°C for a minimum of 1 h in the following solution: 50% formamide, 5× SSC, 2% Roche blocking reagent, 0.1% Triton X-100, 0.5% CHAPS (Sigma), 1mg/ml yeast RNA, 5 mM EDTA, and 50 g/ml heparin. Following prehybridization, labeled probe was added to the prehybridization solution at a concentration of 0.1mg/ml and hybridized to sections overnight at 57°C. Slides were washed in the following solutions: 5× SSC prewarmed to 57°C for 5 min, 0.5× SSC/50% formamide prewarmed to 57°C for 1 h, and 0.5× SSC (room temperature) for 5 min. Sections were then blocked for 1 h in the following blocking solution: 10% sheep serum; 2% BSA; 0.02% sodium azide in 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.1% Triton X-100. Sections were then incubated with an alkaline phosphatase-conjugated anti-DIG antibody (Roche) diluted 1:2000 in blocking solution (1:500 for paraffin sections) for 1 h. Excess antibody was removed through two 10-min washes in 0.05 M Tris (pH 7.5), 0.15 M NaCl, and the pH was re-equilibrated through three 10-min washes in 0.1 M Tris (pH 9.5), 0.05 M MgCl, and 0.1 M NaCl. Slides were incubated overnight with substrates for alkaline phosphate activity, NBT and BCIP (Roche). Following color development, slides were fixed in 4% paraformaldehyde/1× PBS and mounted by using Vectashield (Vector Labs, Burlingame, Calif.).
Functional analysis of Tcf isoforms. Full-length cDNAs representing
SAC183 containing transcripts were amplified by PCR, and a fragment consisting of the entire coding region was subcloned into the pcDNA3.1+ expression vector (Invitrogen, Carlsbad, Calif.) . To assess the ability of novel Tcf7l2 isoforms to alter TCF-responsive reporter gene expression, 293T cells in 6-well plates were transfected by calcium-phosphate coprecipitation, as described (Erickson et al. 2001) . The reporter plasmids used were pTOPFLASH or pFOPFLASH (25 ng; Upstate Biotech, Lake Placid, N.Y.) containing the luciferase reporter gene under the control of multimeric consensus-or mutant inactive-TCF binding sites, respectively. Expression constructs for ␤-catenin (10 ng), ␤-galactosidase (100 ng) and novel Tcf7l2 (corresponding to Fig. 3A , isoform G) were cotransfected. The total mass of DNA per well was kept constant by adding pcDNA3.1+. Cells were lysed after 48 h, and luciferase and ␤-galactosidase activities were assayed as described (Erickson et al. 2001 ). ␤-galactosidase activity was used to normalize for efficiency of transfection. Normalized luciferase activities were compared with values obtained with reporter gene alone and are reported as fold activation.
Results

Morphological differences between wild-type and Prop1
df/df mutant pituitaries are detectable at e14.5 (Gage et al. 1996) , 2 days after peak levels of expression of Prop1 in wild-type mice (Sornson et al. 1996) . Thus, expression of PROP1 target genes involved in expansion and cell specification in the pituitary is expected to peak between e12.5 and e14.5. To identify genes expressed during this critical window, embryonic day e14.5 developing pituitary glands were dissected from Prop1 +/+ and Prop1 df/df embryos, RNA was extracted, and cDNA subtractive hybridization was performed.
Mutant transcripts were subtracted from wild-type transcripts, resulting in a library of clones enriched for genes dependent on PROP1, either directly or indirectly. These transcripts are activated as the pituitary primodium proliferates, doubling in size over a period of 2 days, and the final cell fate decisions necessary for differentiation of somatotropes, thyrotropes, lactotropes, and gonadotropes occur (Carbajo-Perez et al. 1989; Burrows et al. 1999 ). The library of transcripts was cloned, and 480 clones were randomly picked for further analysis.
DNA sequence analysis of each of the clones revealed an average insert size of 600 bp, validated the subtraction method, and showed a low level of redundancy within the subtracted library. Both Pit1 and neuronatin are expressed at lower levels in Prop1 df/df mutant pituitaries relative to wild-type (Gage et al. 1996; Sornson et al. 1996) , and both of these genes were identified in the subtraction products (SAC207 and SAC234, respectively). The majority of clone inserts were sequenced in their entirety, and sequence comparisons demonstrate a low level of redundancy in the library. 70% of the clones are represented one time in the library, 13% are represented two times, and one clone is represented six times in the library. Each clone sequence was compared with known genes and expressed sequence tags (ESTs) via BLASTn searches of the non-redundant (nr) and EST (dbest) databases (Altschul et al. 1997) . Clones exhibiting sequence similarity to many types of genes were identified (Table 1) . Thirty-four percent of the clones, do not have sequence similarity to known genes, but are similar to ESTs (data not shown), and 4% represent novel sequences (GenBank accession numbers BE692930-BE693109).
Expression of a subset of the clones was assessed by using RT-PCR and in situ hybridization. Almost all of the clones tested by RT-PCR were shown to be expressed in the pituitary gland (23/24), confirming the integrity of the dissection. The frizzled2 transcript (SAC265) is present in the developing anterior, intermediate, and posterior lobes (Fig. 1A) . A second transcript, SAC324, is identical to a follistatin-like TGF-␤ inducible gene (Shibanuma et al. 1993) and is expressed in the mesenchymal cells surrounding the developing pituitary gland (Fig. 1C) . Transcripts expressed in and adjacent to the developing pituitary have been identified in this screen.
We have utilized two approaches to identify differentially expressed transcripts in the developing pituitary gland. Approximately 100 expressed sequence tags (ESTs) were generated in a differential display screen (Douglas and Camper 2000) , and approximately 500 ESTs were generated in the cDNA subtraction experiment described here. There is no sequence overlap between Comparisons of embryonic pituitary EST sequences to known genes via BLAST searches revealed that a number of genes involved in the Wingless (Wg)/Wnt signaling pathway are present in the libraries we generated. A novel isoform of the transcription factor, TCF4 (T-cell factor 7 like-2, Tcf7l2), and Apc were identified by using differential display. Partial cDNAs encoding frizzled2 (Fzd2), ␤-catenin, and groucho were identified in the subtraction experiment.
Novel isoforms of Tcf7l2. Clone SAC183 (GenBank accession BG487404) is a 365-bp EST identified through differential display analysis of genes expressed at e12.5 and e14.5 in the developing pituitary gland (Douglas and Camper 2000) . BLASTn analysis of the differential display clone revealed 100% identity over a 136-nucleotide region to Tcf7l2. The last 129 bp of SAC183 shows only 36% identity to known Tcf7l2 isoforms (Fig. 2) . Furthermore, the divergent sequence of SAC183 encodes a stop codon that would terminate the peptide prior to the DNA binding domain. Oligonucleotides designed to the sequence spanning the breakpoint in conservation with other Tcf7l2 isoforms (Fig. 2, primers 1  and 3 ) amplified a product of the predicted size and sequence from adult brain cDNA, indicating that SAC183 is a bonafide transcript (data not shown).
Oligonucleotides designed to the divergent region of SAC183 (Fig. 2, primers 2 and 3 ) and the 3ЈUTR of Tcf7l2 were used for mapping on the T31 mouse/hamster radiation hybrid panel. Both SAC183 and Tcf7l2 map to distal MMU 19 between D19Mit104 and D19Mit50 (data not shown). The human ortholog of Tcf7l2 maps to a region of HSA10q (Duval et al. 2000) that exhibits synteny homology to this region of MMU 19. The mapping data are consistent with the hypothesis that SAC183 is a novel isoform of Tcf7l2.
Both human and mouse Tcf7l2 transcripts are extensively alternatively spliced, and numerous Tcf7l2 mRNA isoforms generating proteins with different C-termini have been previously reported in mouse (summarized in Fig. 3 , A-E; Cho and Dressler 1998; Korinek et al. 1998; Lee et al. 1999; Duval et al. 2000) . To determine the origin of the divergent sequence in clone SAC183, primers flanking the break in conservation between SAC183 and known Tcf7l2 isoforms were used to amplify C57BL/6J genomic DNA (primers 1 and 3, Fig. 2) . The resulting 4.2-kb product was cloned and sequenced (GenBank accession AF363722). Clone SAC183 cDNA sequence was compared with genomic sequence to determine intron/exon boundaries. Interestingly, there is no exon/ exon boundary at the breakpoint in sequence conservation (marked by an asterisk in Fig. 2 ). This implies that intra-exon splicing occurs in the post-transcriptional processing of the Tcf7l2 mRNA.
Clone SAC183 and the Tcf7l2B isoform reported by Lee and colleagues (1999) (represented as schematic C, Fig. 3 ) diverge from the amino terminal consensus sequence at the same residue, indicating a variation of exon/exon boundaries generated by alternative splicing. The amino acid sequence of each previously reported mouse Tcf7l2 isoform (Fig. 3, A-E) and the putative protein sequence of a heart EST (Figure 3, I ) from the Tcf7l2 UniGene cluster (Mm.10712) were aligned. This analysis revealed six isoforms of Tcf7l2. Three different amino terminal and four different carboxy terminal sequences were identified (Fig. 3) .
SAC183 represents a partial transcript; however, the deduced amino acid sequence of SAC183 predicts a truncated protein without a DNA binding domain. Longer cDNAs of the SAC183 isoform were amplified with an oligonucleotide designed to the 5ЈUTR of Tcf7l2 and primer 3 (Fig. 2) . Three different isoforms were identified from both e12.5 and e14.5 pituitary samples (Fig.  3, F-H) . Similar Tcf7l2 isoforms were independently cloned from 3T3-L1 preadipocytes and adipocytes. Two novel, alternatively spliced exons were identified (Fig. 3 , black box in F and Cterminal black box in H). The N-terminal alternatively spliced exon depicted in schematic H has similarity to a human exon and is also present in a heart EST (Fig. 3, I , Duval et al. 2000) . The three alternatively spliced isoforms of Tcf7l2 identified in this study indicate that N-terminal alternative splicing occurs in mouse Tcf7l2. RNase protection assays with SAC183 as a probe show that these novel Tcf7l2 isoforms are present in low amounts relative to previously described Tcf7l2 isoforms (data not shown).
The expression pattern of SAC183 was analyzed by RT-PCR and in situ hybridization. A panel of embryonic tissues, adult tissues, and pituitary cell lines was examined for SAC183 expression by RT-PCR by using oligonucleotides designed to the divergent region of SAC183 (See Materials and methods for tissues examined). SAC183 is widely expressed and was detected in all tissues examined except the eye (data not shown). Interestingly, SAC183 is detected in the Pit1 lineage precursor cell line (GHFT1) but not in corticotrope-like, gonadotrope-like, or thyrotrope-like cells. This suggests that this isoform of Tcf7l2 is not ubiquitously expressed among specialized pituitary cells, leaving open the possibility that it could influence cell differentiation in the pituitary.
In situ hybridization was performed to compare the spatial patterns of expression of Tcf7l2 and SAC183 in e12.5 and e14.5 embryos. No obvious differences were detected (data not shown). Expression was detected at high levels in the thalamus and the roof of the midbrain, and lower levels were detected in the floor of the diencephalon, the anterior hypothalamus, and the pontine flexure. A low but consistent level of expression was detected in the pituitary gland, mesenchymal cells underlying the pituitary, the tongue, and intestinal tissue. This confirms and extends known Tcf7l2 expression sites (Cho and Dressler 1998; Korinek et al. 1998; Lee et al. 1999) .
We hypothesized that the novel Tcf7l2 isoforms would act as endogenous inhibitors of Wnt signaling, because they are predicted to bind ␤-catenin, but not DNA. To test this hypothesis, we performed reporter gene assays, using plasmids containing three copies of consensus (pTOPFLASH) or mutated (pFOPFLASH) TCFbinding sites upstream of the thymidine kinase (TK) minimal promoter and luciferase open reading frame (van de Wetering et al. 1997 ). In the presence of increasing amounts of the Tcf7l2 isoform G, diagrammed in Fig. 3 , the activation of TCF-responsive (2)] are shown aligned to the SAC183 nucleotide sequence. The Tcf7l2B(1) isoform is identical the the Tcf7l2B(2) isoform except for the addition of 15 nucleotides (marked with an asterisk). This is the site where the sequence of SAC183 significantly diverges from other Tcf7l2 isoforms. A termination codon is present shortly after the break in conservation of sequence (indicated by box); thus, the SAC183 transcript is predicted to lack a DNA binding domain. Long arrows indicate oligonucleotides used as PCR primers. Vertical arrows indicate exon/exon boundaries. pTOP-FLASH by exogenous ␤-catenin decreased to levels at or below background (Fig. 3J) . Similar results were observed for the two other novel Tcf7l2 isoforms (data not shown). Total transfected DNA was kept constant by the addition of pcDNA3.1+, which minimizes the possibility of promoter squelching or other nonspecific effects. In addition, ␤-catenin and increasing amounts of the novel Tcf7l2 had no effect on the activity of the negative control, pFOPFLASH (data not shown). This suggests that these novel isoforms may act as endogenous inhibitors by decreasing the ability of ␤-catenin to activate TCF-responsive target genes. However, the mechanism for novel Tcf7l2 isoform action may be more complicated, because these isoforms appear to potentiate ␤-catenin activation of the Cyclin-D1 promoter (data not shown). This suggests the importance of promoter context and functional interactions with transcription factors other than TCF/LEFs.
Parital mouse frizzled2 cDNA. A 560-bp EST (clone SAC265) identified through cDNA subtraction shows sequence similarity to rat, human, and Xenopus orthologs of frizzled2. Each member of the large family of frizzled cell surface receptors has a similar protein structure composed of extracellular cysteine-rich ligand binding and linker domains, seven transmembrane domains, and an intracellular C-terminus (Wodarz and Nusse 1998) . To obtain a longer cDNA of the mouse frizzled2 ortholog identified by clone SAC265, an adult pituitary cDNA library was screened by PCR with SAC265 specific primers, and a 940-bp partial cDNA was identified. Amino acid sequence alignments of the mouse FZD2 sequence identified here (GenBank Accession AF363723), human FZD2 (GenBank Accession NP 001457), rat FZD2 (GenBank Accession AAA41172), and frog FZD2 (GenBank Accession AA06359) revealed complete amino acid identity with human FZD2 and only four amino acid changes compared with either rat or frog FZD2. Thus, we identified the mouse ortholog of FZD2. The recently reported sequence of mouse frizzled10 (Malik and Shivdasani 2000) is 100% identical to mouse frizzled2, and the gene has been officially renamed Fzd2.
The expression pattern of Fzd2 was determined by RT-PCR in a panel of embryonic and adult tissues. Fzd2 expression was detected in embryonic tissues at e12.5 and e14.5 and in adult brain, heart, lung, skeletal muscle, kidney, and pituitary. Fzd2 was not detected in the liver, spleen, testis, or eye. Our expression data are largely consistent with previous reports for mouse, human, and rat Fzd2 expression (Chan et al. 1992; Sagara et al. 1998; Malik and Shivdasani 2000) .
Expression was detected in the embryonic pituitary gland at e12.5 and e14.5 and in the adult pituitary gland by RT-PCR. Fzd2   Fig. 3 . Schematic diagram depicting TCF7L2 isoforms generated by alternative splicing. A-I. The amino acid sequences of each previously reported TCF7l2 isoform were aligned with the deduced amino acid sequences of the novel SAC183-containing transcripts identified in this study. Schematic representations of the alignments are shown. Nonalternatively spliced exons are shown as white boxes, alternatively spliced exons are shown as gray boxes, novel exons reported here are shown as black boxes, and the DNA binding domain is indicated as a hatched box. Asterisks indicate the positions of stop codons. Five alternatively spliced isoforms have previously been described (A-E). Three N-terminal alternatively spliced isoforms were identified in this study (F-H) . The Nterminal novel exon in H (black box) is identical to an exon found in a heart EST (schematized in I). This heart EST represents a partial cDNA, but likely contains a DNA binding domain indicating that N-terminal alternative splicing can occur in TCF7L2 isoforms containing or lacking a DNA binding domain. Amino acid sequences were identified from the following sources: A. TCF7L2E (GenBank Accession AAD16968; Lee et al. 1999 ); B. TCF7L2E (this sequence is not in GenBank; Cho and Dressler 1998); C. TCF7L2B (GenBank accession AAD16967; Lee et al. 1999) ; D. TCF7L2B (this sequence is not in GenBank; Cho and Dressler 1998); E. TCF7L2B (GenBank Accession CAA11071; Korinek et al. 1998 ); F. Longer SAC183 cDNA (GenBank Accession AF363724); G. Longer SAC183 cDNA (GenBank Accession AF363725); H. Longer SAC183 cDNA (GenBank Accession AF363726); I. Heart EST (GenBank Accession AA671377). J. Inhibition of Tcf-responsive reporter (pTOPFLASH) activation by a novel Tcf7l2 isoform in transiently transfected 293T cells. To correct for transfection efficiency, luciferase activity was normalized to ␤-galactosidase activity. Fold activation was determined by comparing luciferase activity to pTOPFLASH alone values. Results are reported as mean luciferase activity ± range (n ‫ס‬ 2) and are representative of three independent experiments. expression was detected in the G7, GHFT1, ␣TSH, and ␣T3 pituitary cell lines, suggesting broad expression within the adult organ (data not shown). Furthermore, the partial frizzled2 cDNA isolated from the adult pituitary cDNA library was used as an in situ hybridization probe. Fzd2 expression is detectable in the developing anterior, intermediate, and posterior lobes of the pituitary gland (Fig. 1A) .
Discussion
PROP1 mutations cause hypoplasia of the pituitary gland and deficiencies in most of the pituitary hormones. No direct targets of PROP1 are known. We have applied the cDNA subtractive hybridization approach to compare transcripts expressed in wild-type and Prop1 df/df embryonic pituitaries at e14.5. The library we report here contains over 350 transcripts, none of which were identified by a differential display screen of embryonic pituitary transcripts (Douglas and Camper 2000) . Ten novel transcripts were identified; thus, this partial expression profile represents a significant advance for the field.
Two genes known to be reduced in Prop1 df/df pituitaries, Pit1 and neuronatin, were identified in the subtracted library, indicating that this library is enriched for PROP1-dependent genes. The library also contains transcripts that encode transcription factors, cell surface molecules, and cell cycle regulators, as well as ESTs not previously known to be expressed in the developing pituitary gland and several novel clones. This library is a resource for identification of targets for genes such as Pitx2, Lhx3, and Hesx1, in addition to Prop1, because each of these genes influences early pituitary development. Validation of differential expression of individual transcripts is necessary and is currently under way.
We demonstrated that a follistatin-like TGF-␤-inducible gene, SAC324, is expressed in the mesenchymal cells surrounding the pituitary gland. This expression pattern is intriguing because several signaling molecules of the TGF␤ superfamily are expressed in the region of the pituitary gland at this time during development (Ericson et al. 1998; Treier et al. 1998 ) and could induce expression of this gene. Furthermore, ventral mesenchymal cells, themselves, secrete signaling molecules important for pitutiary development (Ericson et al. 1998; Treier et al. 1998) .
Comparisons between transcripts identified in a differential display screen (Douglas and Camper 2000 ) and the subtracted library described here reveal that several members of the Wnt signaling cascade are expressed in the developing pituitary gland. We identified a novel isoform of Tcf7l2, the Fzd2 receptor, Apc, ␤-catenin, and groucho in the developing pituitary expression libraries. This is the first report identifying members of the Wnt signaling cascade in the developing pituitary and provides further support for the importance of Wnt signaling in its ontogeny. Specifically, FZD2 and the novel TCF7L2 isoforms might regulate Wnt-mediated developmental cues responsible for specification and expansion of anterior lobe cell types.
The novel Tcf7l2 isoforms we identified reveal two previously unknown alternatively spliced exons. This alternative splicing introduces a novel stop codon that leads to truncation prior to the DNA binding domain. These isoforms decrease activation of a TCF-responsive reporter gene, suggesting that they can act as inhibitors of TCF-responsive gene expression. The SAC183 isoform of Tcf7l2 is expressed in a Pit1 precursor cell line, but is not expressed in cell lines representing differentiated pituitary cell types. This could mean that SAC183 has a role in undifferentiated pituitary cells that is similar to the role of TCF7L2 in the maintenance of intestinal stem cells (Korinek et al. 1998) .
We have identified the mouse ortholog of frizzled2 in this screen and show that it is expressed throughout the developing pituitary. Wnt molecules transmit their signal via frizzled receptors. This identification of Fzd2 in the developing pituitary is the first report of a possible receptor for Wnt molecules expressed in the region.
Many human patients with multiple pituitary hormone deficiencies do not have mutations in HESX1, LHX3, PROP1, or POU1F1 (the human ortholog of Pit1), indicating that other genes regulating the differentiation of these cell types exist. A subset of the transcripts described here may be targets of these transcription factors and could explain pituitary hormone deficiencies with unknown etiology.
